Calculated based on number of publications stored in Pure and citations from Scopus
20202023

Research activity per year

Network

Mori Yuko

  • Fujita Health University
  • Department of Disease Control and Prevention

External person

Hirakawa Mami

  • Fujita Health University
  • Graduate School of Health Sciences

External person

Wulaer B.

  • Nagoya University
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Fujita Health University
  • Advanced Diagnostic System Research Laboratory
  • Department of Disease Control and Prevention
  • Advanced Diagnostic System Research Laboratory

External person

Hasegawa Masaya

  • Fujita Health University

External person

Hasegawa Masaya

  • Nagoya University
  • Meijo University
  • Department of Neuropsychopharmacology
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Department of Hospital Pharmacy
  • Dept. of Neuropsychopharmacology/H.
  • Dept. Neuropsychopharmacology H.
  • Department of Hospital Pharmacy
  • Department of Hospital Pharmacy
  • Fujita Health University

External person

Lee Hsin Jung

  • National Taiwan University
  • Graduate Institute of Pharmacology

External person

Fujigaki Suwako

  • Gifu University
  • National Institutes of Health
  • University of Wollongong
  • Laboratory of Neurotoxicology
  • Department of Laboratory Medicine
  • School of Medicine
  • Department of Laboratory Medicine
  • Department of Informative Clinical Medicine
  • Department of Laboratory Medicine
  • Australian Cataract Research Foundation
  • Fujita Health University
  • Department of Disease Control and Prevention

External person

Kosuge Aika

  • Fujita Health University

External person

Niijima Moe

  • Fujita Health University

External person

Kurahashi Hitomi

  • Fujita Health University

External person

Chiou Lih Chu

  • National Taiwan University
  • Graduate Institute of Acupuncture Science
  • Graduate Institute of Brain and Mind Sciences
  • Graduate Institute of Pharmacology
  • China Medical University Taichung

External person

Libo Zou

  • Shenyang Pharmaceutical University
  • Department of Pharmacology

External person

Knutson Daniel E.

  • University of Wisconsin-Milwaukee
  • Department of Chemistry and Biochemistry

External person

Sakata Takatoshi

  • Fujita Health University

External person

Cook James

  • Department of Chemistry and Biochemistry
  • University of Wisconsin-Milwaukee

External person

Nabeshima Toshitaka

  • Nagoya University
  • Department of Hospital Pharmacy
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Department of Hospital Pharmacy
  • Fujita Health University
  • Japanese Drug Organization of Appropriate Use and Research
  • Advanced Diagnostic System Research Laboratory
  • Meijo University

External person

Wu Chen Yi

  • National Taiwan University

External person

Hada Kazuhiro

  • Nagoya University
  • Department of Neuropsychopharmacology and Hospital Pharmacy

External person

Yang Yang

  • Fujita Health University
  • Shenyang Pharmaceutical University

External person

Matsumoto Yurie

  • Meijo University
  • Nagoya University
  • Department of Chemical Pharmacology
  • Department of Psychiatry
  • Division of Clinical Sciences and Neuropsychopharmacology
  • Department of Psychiatry
  • Department of Psychiatry

External person

Iida Tsubasa

  • Fujita Health University

External person

Sieghart Werner

  • Medical University of Vienna
  • Center for Brain Research

External person

Chang Man Hsin

  • National Taiwan University

External person

Lee Ming Tatt

  • UCSI University
  • National Taiwan University

External person

Jaya Suento Willy

  • Fujita Health University
  • Department of Disease Control and Prevention
  • Universitas Hasanuddin

External person

Huang Wei Jan

  • Graduate Institute of Pharmacognosy
  • Taipei Medical University

External person

Murakami Reiko

  • Fujita Health University

External person

Mamiya Takayoshi

  • Nagoya University
  • Meijo University
  • Japanese Drug Organization for Appropriate Use and Research
  • Japanese Drug Organization of Appropriate Use and Research
  • The Academic Frontier Project for Private Universities
  • Japanese Drug Organization of Appropriate Use and Research
  • Japanese Drug Organization of Appropriate Use and Research
  • Japanese Drug Organization of Appropriate Use and Research
  • Japan Ministry of Health, Labour and Welfare
  • Department of Chemical Pharmacology
  • Department of Neuropsychopharmacology
  • Department of Chemical Pharmacology
  • Comparative Cognitive Science Institutes
  • Dept. of Neuropsychopharmacology/H.
  • Dept. Neuropsychopharmacology H.
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Department Neuropsychopharmacol.
  • Comparative Cognitive Science Institute
  • Research Project on the Risk of Chemical Substances
  • Department of Chemical Pharmacology
  • Dept. of N.
  • Division of Neurogenetics
  • Dept. Neuropsychopharm./Hosp. Pharm.
  • Division of Molecular Carcinogenesis
  • Japanese Drug Organization of Appropriate Use and Research

External person

Furuyashiki Tomoyuki

  • Kyoto University
  • Department of Pharmacology
  • Department of Pharmacology
  • Kobe University

External person

Mihovilovic Marko

  • TU Wien
  • Vienna University of Technology

External person

Suento Willy Jaya

  • Fujita Health University
  • Universitas Hasanuddin

External person

Yamada Kiyofumi

  • Nagoya University
  • Fujita Health University
  • Japanese Drug Organization of Appropriate Use and Research
  • Meijo University
  • Kanazawa University
  • Japan Science and Technology Agency
  • Otsuka Pharmaceutical Co Ltd.
  • The Academic Frontier Project for Private Universities
  • Japanese Drug Organization of Appropriate Use and Research
  • Alexandru Ioan Cuza University of Iaşi
  • Niigata University
  • Japanese Drug Organization of Appropriate Use and Research
  • National Hospital Organization, Japan
  • Hospital Pharmacy
  • Japan Ministry of Health, Labour and Welfare
  • Fac. Pharmaceutical Sci.
  • Division of Life Sciences
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Department of Neuropsychopharmacology
  • Department of Clinical Pharmacy
  • Division of Neurogenetics
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Dept. Neuropsychopharmacology H.
  • Department of Chemical Pharmacology
  • Department of Medicinal Chemistry
  • Advanced Diagnostic System Research Laboratory
  • Department of Hospital Pharmacy
  • Laboratory of Neuropsychopharmacology
  • Department of Respiratory Medicine
  • Dept. of Neuropsychopharmacol./H.P.
  • Department of Chemical Pharmacology
  • Lab. of Neuropsychopharmacology
  • Laboratory of Neuropsychopharmacology
  • Department Neuropsychopharmachology
  • Dept. of Neuropsychopharmacology/H.
  • Department of Hospital Pharmacy
  • Dept. of N.
  • Laboratory of Neuropsychoparmacology
  • Ctr. for Clin. Trial/Clin. Research
  • Laboratory of Neuropsychopharmacology
  • Comparative Cognitive Science Institute
  • Research Project on the Risk of Chemical Substances
  • Department of Clinical Pharmacy
  • Laboratory of Neuropsychopharmacology
  • Department of Neuropsychopharmacology
  • Dept. Neuropsychopharmacol./Hosp. P.
  • Department of Microbiology
  • Department Neuropsychopharmacol.
  • Laboratory of Neuropsychopharmacology
  • Department of Molecular Neurobiology
  • Department of Neuropsychopharnuicology
  • Comparative Cognitive Science Institutes
  • Department of Neuropsychopharmacol
  • Dept. of Neuropsychopharmacology
  • Dept. of Neuropsychopharmacology
  • Lab. of Experimental Therapeutics
  • Department of Hospital Pharmacy
  • Department of Clinical Pharmacy
  • Dept. Neuropsychopharm./Hosp. Pharm.
  • Department of Physiology
  • Division of Molecular Carcinogenesis
  • Japanese Drug Organization of Appropriate Use and Research
  • Graduate School of Natural Science and Technology
  • Japan Agency for Medical Research and Development
  • Japanese Drug Organization of Appropriate Use and Research
  • National Hospital Organization Nagoya Medical Center

External person

Lu Qiaohui

  • Fujita Health University
  • Graduate School of Health Sciences
  • Shenyang Pharmaceutical University
  • Department of Pharmacology

External person

Narumiya Shuh

  • Kyoto University

External person

Nitta Atusmi

  • Nagoya University
  • Gifu Pharmaceutical University
  • Department of Pharmacy
  • Department of Molecular Biology
  • Department of Pharmaceutical Therapy and Neuropharmacology
  • Graduate School of Medicine and Pharmaceutical Sciences
  • Department of Pharmaceutical Therapy and Neuropharmacology
  • University of Toyama
  • Dept. Neuropsychopharmacology H.
  • Department of Neuropsychopharmacology
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Dept. of N.
  • Laboratory of Molecular Biology
  • Department of Hospital Pharmacy
  • Department of Neuroimmunology
  • Department of Neuroimmunology
  • Japanese Drug Organization of Appropriate Use and Research
  • Dept. of Neuropsychopharmacology/H.
  • Department of Neuropsychopharmacology
  • Japanese Drug Organization of Appropriate Use and Research
  • Department of Hospital Pharmacy
  • Department of Clinical Medicine
  • Comparative Cognitive Science Institute
  • The Academic Frontier Project for Private Universities
  • Eisai Co., Ltd.
  • Drug Safety Research Center
  • Division of Molecular Carcinogenesis
  • Japanese Drug Organization of Appropriate Use and Research
  • Japanese Drug Organization of Appropriate Use and Research

External person

Aoyama Yuki

  • Meijo University
  • Nagoya University
  • Department of Chemical Pharmacology
  • Division of Neurogenetics
  • Department of Chemical Pharmacology
  • Comparative Cognitive Science Institutes
  • Department of Psychiatry
  • Department of Neuropsychopharmacology and Hospital Pharmacy
  • Division of Molecular Carcinogenesis

External person